Надана інформація про лікарські засоби призначена виключно для ознайомлення і не є офертою, рекламою чи інструкцією щодо застосування. Продаж, доставка та призначення препаратів через сайт не здійснюються. З питань застосування препарату ви можете записатися на очний прийом або онлайн-консультацію до профільного спеціаліста нашої клініки.
ESAFOSFINA EZAFOSFINA 5g/50ml (ITALY)
One package contains:
- A vial containing 5 g of D-Fructose-1,6-diphosphate sodium salt in lyophilized powder - 5 g of D-Fructose-1,6-diphosphoric acid - 3.75 g.
- A vial containing a solvent - 50 ml of sterile injection solution.
- A vial containing 5 g of D-Fructose-1,6-diphosphate sodium salt in lyophilized powder - 5 g of D-Fructose-1,6-diphosphoric acid - 3.75 g.
- A vial containing a solvent - 50 ml of sterile injection solution.
46у.е.
Energy Restoration Supplement
The active ingredient, D-fructose-1,6-diphosphate, is an intermediate product of cellular metabolism. In other words, it is a precursor to ATP. Naturally, increasing the concentration of this substance in the blood leads to accelerated recovery of energy reserves lost during training.
In the preparation of high-level athletes, especially in speed-strength sports, this supplement has proven to be highly effective and is currently one of the most advanced and widely used.
Active Ingredient:
- D-Fructose-1,6-diphosphate sodium salt in lyophilized powder 5g.
- D-Fructose-1,6-diphosphoric acid 3.75g.
Therapeutic Indications:
- Prevention of physical overstrain and improvement of adaptation to extreme physical exertion.
- Treatment of myocardial ischemic diseases - ischemia and acute myocardial infarction (as part of complex therapy) in addition to cardiokinetic therapy.
- Hypophosphatemia, objectively established in both acute situations and during transfusion therapy, surgical intervention, parenteral nutrition, as well as in chronic diseases associated with reduced phosphate levels, such as chronic alcoholism, prolonged fasting, chronic respiratory failure, malabsorption, severe burns.
- Operations using extracorporeal circulation.
- Peripheral circulatory disorders of the ischemic type.
- Acute alcohol intoxication, alcohol withdrawal syndrome, chronic alcoholism.
Contraindications:
Known hypersensitivity to the drug, hyperphosphatemia, renal failure.
Method of Administration:
Injection is administered intravenously at 10 ml per minute.
The package contains 1 vial.
The active ingredient, D-fructose-1,6-diphosphate, is an intermediate product of cellular metabolism. In other words, it is a precursor to ATP. Naturally, increasing the concentration of this substance in the blood leads to accelerated recovery of energy reserves lost during training.
In the preparation of high-level athletes, especially in speed-strength sports, this supplement has proven to be highly effective and is currently one of the most advanced and widely used.
Active Ingredient:
- D-Fructose-1,6-diphosphate sodium salt in lyophilized powder 5g.
- D-Fructose-1,6-diphosphoric acid 3.75g.
Therapeutic Indications:
- Prevention of physical overstrain and improvement of adaptation to extreme physical exertion.
- Treatment of myocardial ischemic diseases - ischemia and acute myocardial infarction (as part of complex therapy) in addition to cardiokinetic therapy.
- Hypophosphatemia, objectively established in both acute situations and during transfusion therapy, surgical intervention, parenteral nutrition, as well as in chronic diseases associated with reduced phosphate levels, such as chronic alcoholism, prolonged fasting, chronic respiratory failure, malabsorption, severe burns.
- Operations using extracorporeal circulation.
- Peripheral circulatory disorders of the ischemic type.
- Acute alcohol intoxication, alcohol withdrawal syndrome, chronic alcoholism.
Contraindications:
Known hypersensitivity to the drug, hyperphosphatemia, renal failure.
Method of Administration:
Injection is administered intravenously at 10 ml per minute.
The package contains 1 vial.
